vs
ADVANCED ENERGY INDUSTRIES INC（AEIS）とRevvity（RVTY）の財務データ比較。上の社名をクリックして会社を切り替えられます
Revvityの直近四半期売上が大きい（$772.1M vs $489.4M、ADVANCED ENERGY INDUSTRIES INCの約1.6倍）。Revvityの純利益率が高く（12.7% vs 10.7%、差は2.1%）。ADVANCED ENERGY INDUSTRIES INCの前年同期比売上増加率が高い（17.8% vs 5.9%）。Revvityの直近四半期フリーキャッシュフローが多い（$161.8M vs $43.0M）。過去8四半期でADVANCED ENERGY INDUSTRIES INCの売上複合成長率が高い（22.2% vs 9.0%）
Advanced Energy Industries, Inc.は米国コロラド州デンバーに本社を置く多国籍テクノロジー企業です。半導体、フラットパネルディスプレイ、データストレージ、通信ネットワーク機器、工業コーティング、医療機器、太陽電池、建築用ガラスなどの製造向けに高精度な電力変換、計測、制御技術を開発しています。
レブィティ（Revvity, Inc.）は米国のライフサイエンス・診断事業を手がける企業で、製薬およびバイオテクノロジー業界を主な顧客とし、特に新たな細胞治療や遺伝子治療の開発に関連するサービス・製品を提供している。前身は多岐にわたる事業を展開してきた老舗企業パーキンエルマーである。
AEIS vs RVTY — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $489.4M | $772.1M |
| 純利益 | $52.3M | $98.4M |
| 粗利率 | 38.6% | — |
| 営業利益率 | 11.6% | 14.5% |
| 純利益率 | 10.7% | 12.7% |
| 売上前年比 | 17.8% | 5.9% |
| 純利益前年比 | 7.4% | 3.9% |
| EPS（希薄化後） | $1.32 | $0.86 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $489.4M | $772.1M | ||
| Q3 25 | $463.3M | $698.9M | ||
| Q2 25 | $441.5M | $720.3M | ||
| Q1 25 | $404.6M | $664.8M | ||
| Q4 24 | $415.4M | $729.4M | ||
| Q3 24 | $374.2M | $684.0M | ||
| Q2 24 | $364.9M | $691.7M | ||
| Q1 24 | $327.5M | $649.9M |
| Q4 25 | $52.3M | $98.4M | ||
| Q3 25 | $46.2M | $46.7M | ||
| Q2 25 | $25.2M | $53.9M | ||
| Q1 25 | $24.7M | $42.2M | ||
| Q4 24 | $48.7M | $94.6M | ||
| Q3 24 | $-14.9M | $94.4M | ||
| Q2 24 | $15.0M | $55.4M | ||
| Q1 24 | $5.4M | $26.0M |
| Q4 25 | 38.6% | — | ||
| Q3 25 | 37.6% | 53.6% | ||
| Q2 25 | 37.0% | 54.5% | ||
| Q1 25 | 37.2% | 56.5% | ||
| Q4 24 | 37.2% | — | ||
| Q3 24 | 35.8% | 56.3% | ||
| Q2 24 | 35.0% | 55.7% | ||
| Q1 24 | 34.5% | 54.6% |
| Q4 25 | 11.6% | 14.5% | ||
| Q3 25 | 10.6% | 11.7% | ||
| Q2 25 | 7.2% | 12.6% | ||
| Q1 25 | 7.6% | 10.9% | ||
| Q4 24 | 8.2% | 16.3% | ||
| Q3 24 | -3.0% | 14.3% | ||
| Q2 24 | 3.6% | 12.4% | ||
| Q1 24 | 0.2% | 6.8% |
| Q4 25 | 10.7% | 12.7% | ||
| Q3 25 | 10.0% | 6.7% | ||
| Q2 25 | 5.7% | 7.5% | ||
| Q1 25 | 6.1% | 6.4% | ||
| Q4 24 | 11.7% | 13.0% | ||
| Q3 24 | -4.0% | 13.8% | ||
| Q2 24 | 4.1% | 8.0% | ||
| Q1 24 | 1.6% | 4.0% |
| Q4 25 | $1.32 | $0.86 | ||
| Q3 25 | $1.20 | $0.40 | ||
| Q2 25 | $0.67 | $0.46 | ||
| Q1 25 | $0.65 | $0.35 | ||
| Q4 24 | $1.29 | $0.77 | ||
| Q3 24 | $-0.40 | $0.77 | ||
| Q2 24 | $0.40 | $0.45 | ||
| Q1 24 | $0.14 | $0.21 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $791.2M | $919.9M |
| 総負債低いほど良い | $567.5M | — |
| 株主資本純資産 | $1.4B | $7.3B |
| 総資産 | $2.5B | $12.2B |
| 負債/資本比率低いほどレバレッジが低い | 0.42× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $791.2M | $919.9M | ||
| Q3 25 | $758.6M | $931.4M | ||
| Q2 25 | $713.5M | $991.8M | ||
| Q1 25 | $723.0M | $1.1B | ||
| Q4 24 | $722.1M | $1.2B | ||
| Q3 24 | $657.3M | $1.2B | ||
| Q2 24 | $986.1M | $2.0B | ||
| Q1 24 | $1.0B | $1.7B |
| Q4 25 | $567.5M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $564.7M | — | ||
| Q3 24 | $564.0M | — | ||
| Q2 24 | $907.3M | — | ||
| Q1 24 | $911.5M | — |
| Q4 25 | $1.4B | $7.3B | ||
| Q3 25 | $1.3B | $7.4B | ||
| Q2 25 | $1.3B | $7.6B | ||
| Q1 25 | $1.2B | $7.6B | ||
| Q4 24 | $1.2B | $7.7B | ||
| Q3 24 | $1.2B | $7.9B | ||
| Q2 24 | $1.2B | $7.9B | ||
| Q1 24 | $1.1B | $7.8B |
| Q4 25 | $2.5B | $12.2B | ||
| Q3 25 | $2.4B | $12.1B | ||
| Q2 25 | $2.4B | $12.4B | ||
| Q1 25 | $2.3B | $12.4B | ||
| Q4 24 | $2.3B | $12.4B | ||
| Q3 24 | $2.2B | $12.8B | ||
| Q2 24 | $2.5B | $13.4B | ||
| Q1 24 | $2.5B | $13.4B |
| Q4 25 | 0.42× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.47× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.78× | — | ||
| Q1 24 | 0.80× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $80.5M | $182.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $43.0M | $161.8M |
| FCFマージンFCF / 売上 | 8.8% | 21.0% |
| 設備投資強度設備投資 / 売上 | 7.7% | 2.6% |
| キャッシュ転換率営業CF / 純利益 | 1.54× | 1.85× |
| 直近12ヶ月FCF直近4四半期 | $125.9M | $509.4M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $80.5M | $182.0M | ||
| Q3 25 | $78.7M | $138.5M | ||
| Q2 25 | $45.2M | $134.3M | ||
| Q1 25 | $28.9M | $128.2M | ||
| Q4 24 | $82.7M | $174.2M | ||
| Q3 24 | $34.1M | $147.9M | ||
| Q2 24 | $6.7M | $158.6M | ||
| Q1 24 | $7.3M | $147.6M |
| Q4 25 | $43.0M | $161.8M | ||
| Q3 25 | $50.8M | $120.0M | ||
| Q2 25 | $17.1M | $115.5M | ||
| Q1 25 | $15.0M | $112.2M | ||
| Q4 24 | $69.9M | $149.8M | ||
| Q3 24 | $21.4M | $125.6M | ||
| Q2 24 | $-8.1M | $136.6M | ||
| Q1 24 | $-9.3M | $129.7M |
| Q4 25 | 8.8% | 21.0% | ||
| Q3 25 | 11.0% | 17.2% | ||
| Q2 25 | 3.9% | 16.0% | ||
| Q1 25 | 3.7% | 16.9% | ||
| Q4 24 | 16.8% | 20.5% | ||
| Q3 24 | 5.7% | 18.4% | ||
| Q2 24 | -2.2% | 19.7% | ||
| Q1 24 | -2.9% | 20.0% |
| Q4 25 | 7.7% | 2.6% | ||
| Q3 25 | 6.0% | 2.6% | ||
| Q2 25 | 6.4% | 2.6% | ||
| Q1 25 | 3.4% | 2.4% | ||
| Q4 24 | 3.1% | 3.4% | ||
| Q3 24 | 3.4% | 3.3% | ||
| Q2 24 | 4.0% | 3.2% | ||
| Q1 24 | 5.1% | 2.7% |
| Q4 25 | 1.54× | 1.85× | ||
| Q3 25 | 1.70× | 2.97× | ||
| Q2 25 | 1.79× | 2.49× | ||
| Q1 25 | 1.17× | 3.03× | ||
| Q4 24 | 1.70× | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | 0.45× | 2.87× | ||
| Q1 24 | 1.35× | 5.67× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AEIS
| Semiconductor Equipment | $211.6M | 43% |
| Data Center Computing | $177.9M | 36% |
| Industrial And Medical | $78.2M | 16% |
| Telecom And Networking | $21.7M | 4% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
